Home / Inspections / 819726

FDA Inspection 819726 — Center for Fertility and Reproductive Endocrinology UPP

Center for Fertility and Reproductive Endocrinology UPP — FEI 3004081056

The FDA completed an inspection of Center for Fertility and Reproductive Endocrinology UPP on February 26, 2013 in Pittsburgh, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 26, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Pittsburgh, PA (United States)

Facility

Other inspections at this facility

  • 1228172 (NAI Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1158607 (NAI Wed Dec 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1069130 (NAI Wed Aug 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1027413 (NAI Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 972652 (VAI Thu May 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources